Amgen and DaVita enter into new sourcing and supply agreement

Amgen entered into a six-year Sourcing and Supply Agreement with DaVita Inc. to supply EPOGEN and Aranesp for dialysis services in the United States and Puerto Rico, covering at least 90% of DaVita's annual requirements.

“Amgen (NASDAQ:AMGN) today announced it has entered into a six-year Sourcing and Supply Agreement with DaVita Inc.”amgen.com

• 1 source
• amgen.comAmgen And DaVita Enter Into New Sourcing And Supply Agreement| AmgenJan 1, 2017

Summarized from public sources; check the original articles before acting on it.